VIVS
VivoSim Labs, Inc.
NASDAQ: VIVS · HEALTHCARE · BIOTECHNOLOGY
$1.44
-3.36% today
Updated 2026-04-29
Market cap
$4.34M
P/E ratio
0.85
P/S ratio
30.58x
EPS (TTM)
$1.76
Dividend yield
—
52W range
$1 – $5
Volume
0.1M
VivoSim Labs, Inc. (VIVS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2011 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-109425.00 | $-9.69M | $-15.56M | $-19.60M | $-29.37M | $-29.18M | $-28.86M | $-20.38M | $-14.88M | $-13.32M | $-8.45M | $-12.41M | $-14.65M | $-9.46M |
| Capital expenditures | $30000.00 | $357000.00 | $277000.00 | $1.52M | $2.15M | $1.35M | $296000.00 | $79000.00 | $0.00 | $405000.00 | $409000.00 | $396000.00 | $42000.00 | $13000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $1.44M | $4.60M | $7.02M | $8.56M | $7.39M | $6.90M | $5.19M | $4.11M | $5.56M | $2.26M | $2.38M | $1.51M | $532000.00 |
| Free cash flow | $-139425.00 | $-10.05M | $-15.84M | $-21.12M | $-31.52M | $-30.54M | $-29.15M | $-20.45M | $-14.88M | $-13.73M | $-8.86M | $-12.80M | $-14.70M | $-9.47M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — |